Scopus
YÖKSİS Eşleşti
Effects of high intensity interval-based inspiratory muscle training in patients with heart failure: A single-blind randomized controlled trial
Heart and Lung · Kasım 2023
YÖKSİS Kayıtları
Effects of high intensity interval-based inspiratory muscle training in patients with heart failure: A single-blind randomized controlled trial
Heart & Lung · 2023 SCI-Expanded
DOÇENT İSMAİL ÖZSOY →
Makale Bilgileri
DergiHeart and Lung
Yayın TarihiKasım 2023
Cilt / Sayfa62 · 1-8
Scopus ID2-s2.0-85161014589
Özet
Background: Given the promising effects of inspiratory muscle training (IMT), determining the most appropriate IMT protocol will optimize the training benefits. Objectives: The objective of this study was to determine the effects of high intensity interval-based inspiratory muscle training (H-IMT) on cardiovascular, pulmonary, physical, and psychosocial functions in patients with heart failure and reduced ejection fraction (HFrEF). Methods: Thirty-four patients with HFrEF were randomly assigned to the H-IMT or control group for 3 days/week, 8 weeks training period. The H-IMT group performed IMT at least 70% of the maximal inspiratory pressure, whereas the control group performed unloaded IMT. Each session occurred 7 sets with a total of 21 min consisting of 2-min training and 1-min interval. Heart rate variability (HRV), arterial stiffness, respiratory muscle strength and endurance, diaphragm thickness, quadriceps strength, functional capacity, frailty, dyspnea, fatigue, disease-specific health-related quality of life (HRQoL), and generic HRQoL were evaluated at baseline and after 8 weeks training period by blinded assessors. Results: Statistically significant between-group differences were observed in the time domain parameters of HRV, arterial stiffness, inspiratory and quadriceps muscle strength, respiratory muscle endurance, diaphragm thickness, functional capacity, frailty, dyspnea, fatigue, and disease-specific HRQoL in favor of the H-IMT group (p<0.05). Conclusions: H-IMT is an effective protocol for improving cardiac autonomic function, arterial stiffness, inspiratory and quadriceps muscle strength, respiratory muscle endurance, diaphragm thickness, functional capacity, frailty, dyspnea, fatigue, and disease-specific quality of life in patients with HFrEF. Clinical trial registration: NCT04839211
Yazarlar (11)
1
Aylin Tanriverdi
ORCID: 0000-0002-0220-0642
2
Sema Savci
3
Buse Ozcan Kahraman
4
Huseyin Odaman
5
Ebru Ozpelit
6
Bihter Senturk
7
İsmail Özsoy
8
Agah Baran
9
Bahri Akdeniz
10
Serap Acar
11
Ali Balci
Anahtar Kelimeler
Arterial stiffness
Cardiac autonomic function
Diaphragm thickness
Heart failure
Inspiratory muscle training
Kurumlar
Dokuz Eylül Üniversitesi
Izmir Turkey
Klinikum Bremerhaven
Bremerhaven Germany
Selçuk Üniversitesi
Selçuklu Turkey
Metrikler
4
Atıf
11
Yazar
5
Anahtar Kelime